Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $834.48M.
ENTERPRISE VALUE (EV)
$834.48M
Beta Bionics, Inc.
Market Cap
$866.05M
Enterprise Value (EV)
$834.48M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Beta Bionics, Inc. (BBNX) | $866.05M | $834.48M |
| Apnimed, Inc. (APMD)vs › | $864.96M | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $853.35M | $746.73M |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $851.97M | $799.86M |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $892.20M | $874.02M |
| Arbutus Biopharma Corp (ABUS)vs › | $892.87M | $877.32M |
| Alumis Inc. (ALMS)vs › | $835.64M | $808.36M |
| Ardelyx, Inc. (ARDX)vs › | $827.55M | $986.55M |
| Gyre Therapeutics, Inc. (GYRE)vs › | $821.12M | $781.25M |
| Bioventus Inc. (BVS)vs › | $916.63M | $1.15B |
Market Cap
$866.05M
Total Debt
$0.00
Cash
$31.58M
Enterprise Value
$834.48M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
